🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free
    Roche Venture Fund logo

    Roche Venture Fund

    Corporate VC · Basel (Switzerland)

    Corporate VC
    Seed
    Series B
    Cloud/SaaS
    Hardware

    Sign up free to access full profile and submit your pitch.

    About

    Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).

    Visit website ↗

    Investment Criteria

    Sign up free to see full investment criteria and submit your pitch.

    Min. Ticket Size
    $3,000,000
    Max. Ticket Size
    $10,000,000
    Investment Stage
    Seed
    Series B
    Regions
    Eastern Europe
    Southern Europe
    Western Europe
    Northern Europe
    AUM
    850

    Similar Investors

    We use cookies to enhance your experience. Read our Privacy Policy